Welcure Drugs & Pharmaceuticals P/B Ratio
Welcure Drugs & Pharmaceuticals P/B ratio. Welcure Drugs & Pharmaceuticals (WELCURE) P/B ratio is 0.27 (Low), book value per share ₹7.82 vs Healthcare average P/B of 0.03 — Very Low - Significant discount to book value, potential distress or value opportunity. View Welcure Drugs & Pharmaceutical 52-week for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
WELCURE P/B Ratio — Valuation Insights & Book Value Analysis
Welcure Drugs & Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 0.27 (Low). For live price, earnings yield and the full fundamental profile, see WELCURE share price.
- Stock appears undervalued with PB of 0.27, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 93.9% below historical average
- Trading at premium to sector average PB of 0.03
Welcure Drugs & Pharmaceuticals P/B Ratio Historical Trend
WELCURE annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Analyse Welcure Drugs & Pharmaceutical ownership pattern to track promoter, FII and institutional holdings.
WELCURE Historical P/B Ratio — Book Value Per Share & Year-End Price
Welcure Drugs & Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.03 | ₹7.82 | ₹0.20 | ₹97 | Low |
| 2025 | 0.05 | ₹9.2 | ₹0.42 | ₹103 | Low |
| 2024 | 15.17 | ₹0.77 | ₹11.67 | ₹1 | High |
| 2023 | 2.5 | ₹1.54 | ₹3.85 | ₹2 | Moderate |
WELCURE vs Healthcare Peers — P/B Ratio Comparison
Welcure Drugs & Pharmaceuticals P/B 0.27 vs Healthcare average 0.03, median 0.67 — range -6.55–1.16.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |